Archer is advancing molecular pathology with a robust technology platform for genetic mutation detection by next-generation sequencing.  By combining the patented Anchored Multiplexed PCR (AMP™) chemistry in an easy-to-use, lyophilized format and powerful bioinformatics software, the Archer® platform dramatically enhances genetic mutation identification and discovery. ArcherDX provides oncology-focused research products and is pursuing regulatory approval for multiple companion diagnostic assays.


Founded 2012
Partnered 2013